Special Issue "Nanomaterials for Cancer Therapies"
A special issue of Nanomaterials (ISSN 2079-4991).
Deadline for manuscript submissions: closed (31 March 2016).
Interests: mesoporous silica-based materials; hybrid organic-inorganic mesoporous materials; multifunctional mesoporous materials; stimuli-responsive hybrid materials; stimuli-responsive hybrid porous materials; self assembling materials.
Special Issues and Collections in MDPI journals
This Special Issue of Nanomaterials, “Nanomaterials for Cancer Therapies,” focuses on new approaches for developing nanostructured devices that are able to replace systemic chemotherapy with localized or intracellular drug release, so as to reduce toxicity and side effects, while maximizing therapeutic efficacy.
The original research papers published in this Special Issue will highlight the relationship between device structure and the device's ability to respond to stimuli, or to themselves induce modifications in living organisms, such as in cancer cells. From this point of view, the Special Issue will present an engineering approach that is inspired by the biological specificity of tumor structures, and which represents a methodological benchmark for research groups involved in the development of smart cancer therapies within the different areas of nanomaterials. In this way, the publication of high level articles will contribute toward, and allow for, the rapid diffusion of results and a rapid increase in scientific progress.
Dr. Luigi Pasqua
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- nanostructured drug targeting devices
- nanomaterials for cancer
- smart cancer therapies
- intracellular drug release
- cancer nanotechnology
- nanodevices for cancer therapies
- multifunctional drug targeting devices
- stimuli-responsive nanomaterials
- stimuli-responsive therapeutic devices
- biological response triggering devices